Grants for Researchers
1,022 open opportunities. Open federal research funding for universities, research institutions, and individual investigators — with plain-English eligibility, deadlines, and award sizes.
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
Due Nov 16, 2027National Institutes of Health · Amount varies
This NIDDK (R21) opportunity funds basic and translational pilot research on biological, behavioral, and social mechanisms contributing to HIV pathogenesis within NIDDK's mission. It is intended for research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityPilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
Due Nov 16, 2027National Institutes of Health · Up to $100K
This NIH (R03) opportunity funds pilot projects generating preliminary data on a defined list of understudied proteins associated with rare diseases. It is intended for research and academic institutions; foreign organizations are not eligible to apply. The maximum award is about $100,000.
ResearchersSchools & universitiesSmall awardNarrow eligibilityChemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Due Nov 18, 2027National Institutes of Health · Up to $300K
This NIH (R01) opportunity funds basic research into the harmful effects of acute exposure to ultra-potent synthetic opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations, including delayed effects. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. The maximum award is about $300,000.
ResearchersSchools & universitiesNarrow eligibilityDEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
Due Nov 20, 2027Dept of the Army -- Materiel Command · Amount varies
This U.S. Army Research Laboratory Broad Agency Announcement solicits foundational (basic and applied) research proposals supporting Army modernization. Eligibility is broad, including universities, nonprofits, state and local governments, foreign organizations, and for-profit firms (large and small businesses). It uses a competitive merit-based process; no specific award amount is stated.
ResearchersNonprofitsSmall businessSchools & universities+2 moreAccelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Due Dec 3, 2027National Institutes of Health · Amount varies
This NIH (R01) opportunity funds innovative analysis of existing social, behavioral, administrative, and neuroimaging datasets to study substance-use behaviors, related disorders, prevention, and health-service use. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityAccelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Due Dec 3, 2027National Institutes of Health · Amount varies
This NIH (R21) opportunity funds innovative analysis of existing social, behavioral, administrative, and neuroimaging datasets to study substance-use behaviors, related disorders, prevention, and health-service use. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityCatalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Due Dec 23, 2027National Institutes of Health · Up to $350K
This NHLBI Catalyze (R33) opportunity funds rigorous validation of transformative, multi-use platforms or technologies that can advance detection, diagnosis, treatment, or prevention of heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. The maximum award is about $350,000.
ResearchersSchools & universitiesNarrow eligibilityCatalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Due Dec 23, 2027National Institutes of Health · Amount varies
This NHLBI Catalyze (R33) opportunity funds early-stage translational work to identify and characterize therapeutic candidates and combination products (small molecules and biologics) for heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityCatalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Due Dec 23, 2027National Institutes of Health · Amount varies
This NHLBI Catalyze (R33) opportunity funds early-stage translational work to optimize medical device prototypes, develop diagnostic assays, and create research tools for heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityCatalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Due Dec 23, 2027National Institutes of Health · Amount varies
This NHLBI Catalyze (R61/R33) phased opportunity funds medical device prototype design and testing, disease-target identification, and assay development for heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityCatalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Due Dec 23, 2027National Institutes of Health · Amount varies
This NHLBI Catalyze (R61/R33) phased opportunity funds target identification and validation plus preliminary product or lead-series identification for small molecules, biologics, and combination products treating heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements
Due Dec 31, 2027National Park Service · $0
This National Park Service opportunity offers Master Cooperative Agreements to participants in the Cooperative Ecosystem Studies Units (CESU) network across listed regions, supporting research, technical assistance, education, and capacity building. Only existing CESU network partners may apply, so applicants must already have joined the network. No specific award amount is provided.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityDEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH
Due Jan 4, 2028Dept of the Army -- Materiel Command · Amount varies
This U.S. Army DEVCOM Analysis Center Broad Agency Announcement solicits applied-research proposals supporting Army modernization, tool development, and data curation. Eligibility is broad, including universities, nonprofits, state and local governments, foreign organizations, and for-profit firms (large and small businesses). It uses a whitepaper-then-proposal process; no specific award amount is stated.
ResearchersNonprofitsSmall businessSchools & universities+2 moreNIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Due Jan 6, 2028National Institutes of Health · Up to $500K
This NIDCR (UG3/UH3) cooperative agreement funds planning and implementation of behavioral and social intervention clinical trials for dental, oral, or craniofacial conditions, with a milestone-driven planning phase before transition to a full trial. A clinical trial is required. It is aimed at research and academic institutions; foreign organizations are not eligible. The maximum award is about $500,000.
ResearchersSchools & universitiesLarge awardNarrow eligibilityNIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Due Jan 6, 2028National Institutes of Health · Amount varies
This NIDCR (UG3/UH3) cooperative agreement funds planning and implementation of drug, biologic, device, or procedure intervention clinical trials within NIDCR's mission. A clinical trial is required. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityStimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Due Jan 6, 2028National Institutes of Health · Amount varies
This NIH SHINE (R01) opportunity supports innovative basic and early translational research in nonmalignant hematology, relevant to NIDDK, NIA, and NHLBI missions. It is intended for research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityContinuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
Due Jan 6, 2028National Institutes of Health · Amount varies
This NIDCR (UH3) opportunity funds competing renewal or competitive revision of ongoing clinical trials already supported by NIDCR; a clinical trial is required. Because it continues existing NIDCR-funded trials, it is effectively limited to current grantees and not open to new projects. It is aimed at research and academic institutions; foreign organizations are not eligible. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityModular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R01) opportunity supports investigator-initiated research in cancer control and population sciences, including epidemiology, survivorship, behavioral interventions, and health-data science. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is given.
ResearchersSchools & universitiesNarrow eligibilityMood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R21) opportunity funds translational research into mood and psychosis symptoms during the menopause transition, examining underlying neurobiological and behavioral mechanisms. It targets research and academic institutions and interdisciplinary research teams, not individuals or typical nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIDCR (R03) small-grant program supports pilot or feasibility studies in oral, dental, and craniofacial research by scientists early in establishing an independent research career. It is intended for new-investigator researchers at eligible institutions; foreign organizations are not eligible to apply. No specific award amount is stated, though R03 awards are typically modest.
ResearchersSchools & universitiesNew orgs OKNarrow eligibility